Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TECHNO: Neoadjuvant EC followed by Paclitaxel/Trastuzumab in HER2+ Breast Cancer
NCT00795899Phase 2Completed
- Sponsor
- GBG Forschungs
- Start
- Jan 2002
- Primary completion
- Dec 2005
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab in breast cancer, sponsored by GBG Forschungs. Started Jan 2002; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00795899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00795899.